CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Index trend and stocks in action on February 10, 2020

DSIJ Intelligence-3 0 1231 Article rating: 4.7

Nifty has already shown a few signals of exhaustion at current levels. There is a high probability that the consolidation that has begun may stretch to the coming week as well and during this consolidation phase, it’s important that Nifty should hold above 12,000 mark. Stocks in news: Dr Reddy’s Laboratories, Ultratech Cement, UPL, OM Metal Infraprojects, Cipla, Maruti Suzuki India.

D-Street braces for an unwelcome start!

DSIJ Intelligence-3 0 617 Article rating: 5.0

The news from domestic as well as from the global front is not encouraging for the Indian markets on Monday. Firstly, the death toll from a coronavirus outbreak surpassed the SARS epidemic and secondly, TV exit polls are indicating thumbs up for Aam Aadmi Party (AAP) in Delhi. All-in-all, D-street braces for an unwelcome start to the week. Currently, SGX Nifty is down by 2 points trading at 12,082 levels.

Profit booking can be seen

DSIJ Intelligence-3 0 1868 Article rating: 5.0

The bulls continued to march higher and recorded gains for the fourth consecutive day after RBI left policy rates unchanged but maintained its accommodative stance to boost growth. However, on candlestick pattern, there is a formation of ‘spinning top’ like candle and a V-shaped recovery formation of this pattern indicates profit booking.

Aditya Birla Fashion gains on healthy Q3FY20 numbers

Nidhi Jani 0 3201 Article rating: 3.2

Its consolidated revenue for the quarter Q3FY20 came in at Rs 2,582.74 crore, as against Rs 2,281.55 crore in the corresponding quarter last year, registering 13.2 per cent YoY increase. EBITDA for the quarter grew by 136.1 per cent YoY to Rs 408.29 crore, as against Rs 172.93 crore in the corresponding quarter last year, with a corresponding margin expansion of 823 bps.

Dilip Buildcon bags NHAI project worth Rs 861 crore

Apurva Joshi 0 4616 Article rating: 3.0

Dilip Buildcon Limited has been declared as L-1 bidder for a new Hybrid Annuity Model (HAM) project, four-lane with paved shoulder configuration of Patrapali-Katghora (Km 53.300 to Km 92.600) Pkg-II of Bilaspur-Katghora section of NH-111, New NH-130 in the state of Chhattisgarh under Bharatmala on Hybrid Annuity Model by the National Highways Authority of lndia (NHAI).

RBI Monetary Policy & Q3 results in focus

DSIJ Intelligence-3 0 860 Article rating: 3.0

In the last session, the bulls scored a hat-trick of gains and reclaimed the 12,000 mark on Nifty. On Thursday, the pitch is firm for the bulls to bat on and extend its upmove for the fourth straight day as global cues are cheerful. However, SGX Nifty in the early trend is indicating a cautious start ahead of the RBI’s Monetary Policy Committee’s policy outcome.

HAL signs MoU at DefExpo 2020

DSIJ Intelligence 0 1304 Article rating: 4.3

Hindustan Aeronautical Limited (HAL) announced on Wednesday that it had signed a Memorandum of Understanding (MoU) with Israel Aerospace Industries Limited (IAI) and Dynamatic Technologies Limited (DTL), for the marketing, manufacturing and selling of IAI's Unmanned Aerial Vehicles (UAVs) to Indian Defence customers such as the Indian Defence Force (IDF), Paramilitary Forces and Central Armed Forces.

USFDA approves Valganciclovir Hydrochloride of Granules India

Apurva Joshi 0 1436 Article rating: 2.7

Granules India on Wednesday said that Granules Pharmaceuticals, a wholly-owned foreign subsidiary of Granules India Limited, has received an approval from US Food & Drug Administration (USFDA) for Oral Solution 50 mg/ml of Valganciclovir Hydrochloride, which is bioequivalent to Reference Listed Drug (RLD) Valcyte for Oral Solution 50 mg/ml of Roche Palo Alto LLC.

Index trend and stocks in action on February 05, 2020

DSIJ Intelligence-3 0 1282 Article rating: 5.0

The Budget Day high of 12,017 is likely to act as an immediate resistance for the index. Moving past this resistance zone is likely to help bulls reclaim its 20-DMA which currently stands at 12,140. On the downside, a support is seen at the opening upside gap area (11,783-11,750). Stocks in news: Reliance Industries, Cadila Healthcare, Teamlease Services, BEML, Sun Pharmaceutical.

A glimpse of hope for bulls!

DSIJ Intelligence-3 0 639 Article rating: 5.0

SGX Nifty is indicating a positive start of the day and what’s helping the cause are positive global cues and a steep fall in crude oil prices. Currently, SGX Nifty is trading up by 15 points at 11,722 level. However, we will advise the readers to be cautious and not jump or start buying.

RSS
First365366367368370372373374Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR